Patent · US Expired

sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases

US8409815B2 · kind B2 · utility

4Cited by

4References

14Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

Andreas M. Zeiher · Glückstadt, DE
Christopher Heeschen · Frankfurt am Main, DE
Stefanie Dimmeler · Frankfurt am Main, DE
Christian Hamm · Bad Homburg vor der Höhe, DE

Key dates

Filing date	Nov 10, 2003
Grant date	Apr 2, 2013
Priority date	—
Expiry date	May 10, 2026

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/32
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.